Group N | Group A | Group E | Group AE | P | Power‖ | |
---|---|---|---|---|---|---|
n | 1228 | 110 | 1381 | 346 | ||
Age (years) | 70.6 ± 5.1‡§ | 70.5 ± 5.1 | 70.0 ± 4.7* | 69.5 ± 4.6* | .001 | 0.952 |
BMI (kg/m2) | 22.1 ± 2.6‡§ | 22.4 ± 2.8‡§ | 24.1 ± 2.9*†§ | 25.0 ± 2.9*†‡ | <.001 | 1.000 |
Waist (cm) | 80.0 ± 7.9‡§ | 80.5 ± 7.9‡§ | 86.0 ± 8.3*†§ | 88.6 ± 8.0*†‡ | <.001 | 1.000 |
SBP (mm Hg) | 130.7 ± 20.3‡§ | 130.4 ± 19.2 | 133.7 ± 19.0* | 135.4 ± 18.1* | <.001 | 0.992 |
DBP (mm Hg) | 74.1 ± 11.2‡§ | 74.1 ± 10.7§ | 76.5 ± 11.3* | 77.8 ± 11.3*† | <.001 | 1.000 |
FPG (mg/dL) | 100.1 ± 13.8‡§ | 103.2 ± 24.4§ | 105.3 ± 22.4*§ | 109.5 ± 24.2*†‡ | <.001 | 1.000 |
TC (mg/dL) | 197.3 ± 33.6‡§ | 193.2 ± 37.3§ | 201.3 ± 33.3* | 204.6 ± 36.2*† | <.001 | 0.977 |
HDL-C (mg/dL) | 54.9 ± 14.7‡§ | 54.6 ± 14.9‡§ | 49.8 ± 13.1*†§ | 47.3 ± 13.8*†‡ | <.001 | 1.000 |
LDL-C (mg/dL) | 122.9 ± 30.0‡ | 117.8 ± 36.0‡§ | 126.4 ± 30.3*† | 127.6 ± 32.7† | .001 | 0.951 |
Log TG | 1.95 ± 0.18‡§ | 1.97 ± 0.20‡§ | 2.05 ± 0.20*†§ | 2.12 ± 0.21*†‡ | <.001 | 1.000 |
Data are shown as mean ± SD. Group N: normal ALT and liver echogenicity; group A: elevated ALT and normal liver echogenicity; group E: normal ALT and abnormal liver echogenicity; group AE: elevated ALT and abnormal liver echogenicity.
* P < .05 against group N.
† P < .05 against group A.
‡ P < .05 against group E.
§ P < .05 against group AE.
‖ The retrospective power of one-way analysis of variance was calculated using SPSS general linear model procedures.
BMI: body mass index; SBP: systolic blood pressure; DBP: diastolic blood pressure; FPG: fasting plasma glucose; TC: total cholesterol; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; Log TG: log transformation of triglyceride.